Combined OX40L and mTOR blockade controls effector T cell activation while preserving T reg reconstitution after transplant
- 20 September 2017
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (408)
Abstract
OX40L blockade synergizes with sirolimus to prevent GVHD by controlling effector T cell activation while supporting T reg reconstitution.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (award307997, HL11879)
- National Heart, Lung, and Blood Institute (award307998, HL56067)
- National Heart, Lung, and Blood Institute (award308000, HL095791)
- National Institute of Allergy and Infectious Diseases (award307999, AI34495)
- National Institute of Allergy and Infectious Diseases (award308001, AI051731)
This publication has 79 references indexed in Scilit:
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011
- Immunogenetic Management Software: a new tool for visualization and analysis of complex immunogenetic datasetsImmunogenetics, 2011
- Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationBone Marrow Transplantation, 2011
- A non‐redundant role for OX40 in the competitive fitness of Treg in response to IL‐2European Journal of Immunology, 2010
- Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell DiseaseNew England Journal of Medicine, 2009
- Major histocompatibility complex genotyping with massively parallel pyrosequencingNature Medicine, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Engagement of the Type I Interferon Receptor on Dendritic Cells Inhibits T Helper 17 Cell Development: Role of Intracellular OsteopontinImmunity, 2008
- CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific EffectorsTransplantation and Cellular Therapy, 2008
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003